October 05, 2021
06/10/2021
October 05, 2021
LA JOLLA, CA The 3-year observational results of a novel, direct-to-participant clinical trial, found that people who wore heart rhythm-recording patches for early detection of atrial fibrillation (AFib) had a lower rate of stroke, heart attack, or other major vessel-blocking blood clots three years later, compared to a control group of people whose AFib was diagnosed in the ordinary way at doctors' offices or hospitals.
The results, published in PLoS One, also include the finding that there was a strikingly high chance of these cardiovascular events in the four weeks surrounding ordinary AFib diagnoses, versus virtually zero chance with diagnoses via the patch.
On the whole our results support the idea that screening for AFib with wearable tech, in an appropriately defined population, might be able to meaningfully reduce the risks of strokes and other adverse cardiovascular events and that that issue should be resolved in more conclusive trials, says study senior author Steven Steinhubl, MD, an associate professor at the Scripps Research Translational Institute.
AFib is the most commonly diagnosed heart arrhythmia. Researchers estimate that between three and six million older adults in the U.S. have it, although studies suggest that up to 30 percent of cases are undiagnosed. The abnormal heartbeat rhythm of AFib disrupts cardiac blood flow and promotes clot formation, and AFib is a risk factor for strokes, heart attacks, blood clots outside the brain and heart, and heart failure.
AFib is often diagnosed only after a cardiovascular emergency has occurred, which hints that early detection would allow patients to avoid such emergencies by adopting preventive measures including blood thinner medicines and a healthier diet.
Steinhubl and colleagues set up the mHealth Screening To Prevent Strokes (mSToPS) trial six years ago to investigate this question in a pragmatic, patient-centric way, teaming with the study sponsor, Janssen Pharmaceuticals, along with health insurer Aetna to gather participants, and iRhythm, the maker of a wearable electrocardiogram patch called the Zio XT. There were 1,738 participants who underwent active monitoring. Results after one year, which were published in 2018, showed that monitoring with the patch was associated with significantly more AFib diagnoses, as well as more initiation of anticoagulant medicines.
The new paper focuses on clinical outcomes, including cardiovascular outcomes after three years. The main finding was that in comparison to matched non-participants from the Aetna database, those who participated in the trial and wore a patch had a 20 percent lower rate of cardiovascular adverse events, defined as any stroke, heart attack, or other major vessel-blocking blood clot (systemic embolism). However, this prespecified primary endpoint can only be considered exploratory because the rate of AFib remained significantly different at three years between the two cohorts, which was not hypothesized to be the case.
The researchers also found that the clinical circumstances surrounding AFib diagnosis were radically different depending on how it was diagnosed. Among those diagnosed in the ordinary way, in doctors' offices and hospitals, 6.6 percent had a stroke, 10.2 percent were newly diagnosed with heart failure, 9.2 percent had a heart attack, and 1.5 percent had a systemic embolism, in the four weeks surrounding their diagnosis. By contrast, those diagnosed via screening with the patch included only a single case of newly diagnosed heart failure and no heart attacks, strokes, or emboli in the four-week period surrounding the diagnosis.
As Steinhubl emphasizes, the study as designed could not show conclusively that patch-based screening improves health outcomes. For example, the patch-wearing group was actively recruited into the study and might thus have been more motivated to protect their health whereas the comparison group was not. But he adds that AFib is such a strong risk factor for clot-related problems that early detection and treatment likely would have benefits for many patients.
It's a hard thing to show conclusively, he says. We need to learn more about whom to screen and when to screen in order to prevent, with anticoagulants or even simple lifestyle interventions, what is obviously a large risk of bad outcomes in people who wait to be diagnosed clinically.
Three-year clinical outcomes in a nationwide, observational, siteless clinical trial of atrial fibrillation screening - mHealth Screening to Prevent Strokes (mSToPS) was co-authored by Steven Steinhubl, Jill Waalen, Lauren Ariniello, Gail Ebner, Katie Baca-Motes, and Eric Topol, of Scripps Research Translational Institute; Anirudh Sanyal and Alison Edwards of Healthagen LLC; Robert Zambon of Janssen Research and Development; and Troy Sarich of Johnson & Johnson.
The research was supported by a research grant from Janssen Pharmaceuticals. Additional support was provided by a National Institutes of Health's National Center for Advancing Translational Sciences grant (UL1TROO1114) and a grant from Qualcomm Foundation.
Heart Disease Steinhubl, Steven Translational Institute
LINK: | https://www.scripps.edu/news-and-events/press-room/2021/20211005-stein... |
See more stories from scripps |
More from Scripps
20/04/2024
April 19, 2024
New copper-catalyzed C-H activation strategy from Scripps Research Two-mode reactions inspired by human detox enzymes offer powerful new tools for drug discover...
12/04/2024
April 11, 2024
Scripps Research chemists devise easier new method for making a common type of building block for drugs Scientists transform simple linear amines into saturated...
06/04/2024
April 05, 2024
A simple, inexpensive way to make carbon atoms bind together A Scripps Research team uncovers a cost-effective method for producing quaternary carbon molecules,...
04/04/2024
April 03, 2024
Developing a vaccine for the zombie drug xylazine Scripps Research chemical biologists design an early proof-of-concept vaccine that could lead to the first...
30/03/2024
March 29, 2024
How blocking a neural receptor responsible for addiction could reduce alcohol use A Scripps Research team found that a new therapeutic that targets the kappa op...
13/03/2024
March 13, 2024
New computational strategy boosts the ability of drug designers to target proteins inside the membrane Customized-design approach could streamline the design of...
29/02/2024
February 29, 2024
Scripps Research scientists reveal how first cells could have formed on Earth New phospholipid discovery brings researchers closer to understanding how primordi...
29/02/2024
February 28, 2024
How molecular handedness emerged in early biology Scripps Research chemists fill a major gap in origin-of-life theories. February 28, 2024 LA JOLLA, CA Mole...
22/02/2024
February 21, 2024
Snaking toward a universal antivenom Scripps Research scientists discovered antibodies that protect against a host of lethal snake venoms. February 21, 2024 ...
06/02/2024
February 06, 2024
Calibr-Skaggs announces expansion of option and license agreement with AbbVie to develop novel cell therapies for solid tumors and autoimmune diseases AbbVie...
26/01/2024
January 25, 2024
Re-energizing mitochondria to treat Alzheimer's disease Scripps Research team restored neuron-to-neuron connections in human cells. January 25, 2024 LA JO...
24/01/2024
January 04, 2024
100 years of Science Changing Life: Scripps Research celebrates a century of transforming human health For the last century, institute leaders and renowned scie...
23/01/2024
January 23, 2024
New technology lets researchers track brain cells' off switches The method could shed light on what goes awry in numerous brain conditions when neurons ar...
09/01/2024
January 08, 2024
Three decades of giving: Announcing the Calibr-Skaggs Institute for Innovative Medicines The ALSAM Foundation, founded by the Skaggs family, provides lasting g...
04/01/2024
January 03, 2024
Life science entrepreneur Gene Lay joins Scripps Research Board of Directors Lay, founder of the global biotech company BioLegend, brings invaluable experience ...
21/12/2023
December 20, 2023
Taming a plant-derived toxin Scripps Research team modifies the traditional poison picrotoxinin for potential neurological drugs and anti-parasite treatments. ...
19/12/2023
December 18, 2023
Scripps Research Executive Vice President Eric Topol gives TED talk on transformative power of AI in medicine Topol provides an overview of how AI models can i...
13/12/2023
December 12, 2023
New AI-powered algorithm could better assess people's risk of common heart condition Early detection of atrial fibrillation can reduce the risk of stroke an...
07/12/2023
December 06, 2023
Nanoparticle flu vaccine design shows promise in early tests Scripps Research-designed vaccine could provide broad, enduring protection against influenza A str...
16/11/2023
November 15, 2023
Numerous Scripps Research scientists named Highly Cited Researchers Clarivate's annual, global list represents researchers who have demonstrated significant...
07/11/2023
November 06, 2023
Multiple sclerosis drug invented at Scripps Research slows long-term devastating disease progression Late-breaking data reinforces the effectiveness and safety ...
05/10/2023
October 04, 2023
Keren Lasker named a 2023 Moore Inventor Fellow The prestigious award will support Lasker's inventive research in membraneless organelles and their applica...
22/09/2023
September 21, 2023
Michael Bollong named a 2023 Amgen Young Investigator The prestigious award will support Bollong's research identifying new molecular targets and therapeuti...
09/09/2023
September 08, 2023
Philip Dawson receives 2024 American Chemical Society National Award Dawson is honored with the Arthur C. Cope Late Careers Scholar Award for his foundational c...
07/09/2023
September 06, 2023
Scripps Research chemists devise a method for C-H activation of alcohols The method represents a new toolkit for making drugs and other compounds. September 06...
31/08/2023
August 30, 2023
Scripps Research receives $1.5M to surveil infectious disease threats in wastewater Bill & Melinda Gates Foundation award to support the development of multi-pa...
16/08/2023
August 16, 2023
How cold temperatures trigger the brain to boost appetite Scripps Research scientists' discovery could lead to new weight loss and metabolic health treatmen...
08/08/2023
August 07, 2023
Human antibody that targets carfentanil, fentanyl and related opioids reverses overdose effects in preclinical study Scripps Research-developed antibody therapy...
04/08/2023
August 03, 2023
How sensory neurons impact the gut Scripps Research scientists show that the receptor PIEZO2 in sensory neurons controls gut motility and transit time, which a...
26/07/2023
July 26, 2023
AbbVie and Calibr Expand Strategic Collaboration to Advance Several Preclinical and Early-stage Clinical Assets The expanded strategic collaboration will advan...
23/07/2023
July 21, 2023
Scripps Research scientists develop AI-based tracking and early-warning system for viral pandemics Machine-learning system effectively predicts emergence of pro...
19/07/2023
July 19, 2023
Monitoring T cells may allow prevention of type 1 diabetes Scripps Research study shows that analyzing T cells in blood samples could be used to select at-risk ...
19/07/2023
July 18, 2023
Scripps Research mourns passing of leading organic chemist Albert Eschenmoser Eschenmoser pioneered key reactions in synthetic chemistry and shaped the understa...
15/06/2023
June 14, 2023
Scripps Research awarded $46.8 million by NIH to promote human health through innovative translational science and training The Translational Institute is harne...
13/06/2023
June 13, 2023
Scripps Research's Danielle Grotjahn named 2023 Pew Scholar in the Biomedical Sciences The award will support Grotjahn's study of how cells assemble the...
31/05/2023
May 31, 2023
Crossing the ring: new method enables C-H activation across saturated carbocycles Scripps Research chemists add another powerful tool to their molecular editin...
24/05/2023
May 23, 2023
Scripps Research develops behind-the-scenes tool for better biomedical data discovery The new resource makes datasets more discoverable for life science communi...
19/05/2023
May 15, 2023
Scripps Research neuroscientist Hollis Cline elected to American Academy of Arts and Sciences Cline is recognized for her discoveries about the role of sensory ...
19/05/2023
May 18, 2023
Scripps Research's Skaggs Graduate School awards doctoral degrees to 31st graduating class Commencement ceremony will be livestreamed via Zoom and on instit...
13/05/2023
May 12, 2023
A better route to benzocyclobutenes, sought-after building blocks for drugs Scripps Research chemists devise a new, C-H activation-based method for the synthesi...
09/05/2023
May 08, 2023
Renowned Scripps Research professor Jeffery Kelly elected to National Academy of Sciences Kelly's groundbreaking work on protein misfolding has led to thera...
28/04/2023
April 27, 2023
Mirror-image molecules pave new path for cancer drug discovery By comparing how mirror image versions of small molecules impact clusters of proteins, Scripps R...
22/04/2023
April 21, 2023
How alcohol consumption contributes to chronic pain A Scripps Research team showed how both alcohol intake and alcohol withdrawal can lead to increased pain and...
21/04/2023
April 20, 2023
Xin Jin receives dual awards to study autism risk genes in neurodevelopment Major grants from the National Institutes of Health and California Institute for Reg...
20/04/2023
April 19, 2023
Trim the sugar: New HIV vaccine design improves immune response Scripps Research vaccine candidate headed for clinical trials. April 19, 2023 LA JOLLA, CA A...
18/04/2023
April 17, 2023
Therapeutic can seek and destroy potent opioid to treat overdoses Scripps Research chemists developed a new biologic to work against the synthetic opioid carfen...
07/03/2023
March 06, 2023
How heavy alcohol consumption increases brain inflammation The findings by a Scripps Research team point toward a potential new drug target for treating alcohol...
02/03/2023
March 01, 2023
Scientists find human antibodies that can block multiple coronaviruses including SARS-CoV-2 Results from a Scripps Research and UNC team pave the way for a vacc...
28/02/2023
February 28, 2023
$10 million grant funds Scripps Research Alcohol Research Center through its 50th year The five-year grant supports research into the neurobiology of alcohol us...
28/02/2023
February 27, 2023
Immune system drug shows promise in treating alcohol use disorder, a Scripps Research clinical trial reports Scientists at Scripps Research found that apremilas...